Physician profile
Harvinder Birk
NPI 1417909854
$5,340.97
in general payments reported to CMS, 2019-2025
30 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,978 · 2020: $2,303 · 2021: $60.37.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,065.27 | 2019 | |
| Genzyme Corporation | $1,028.23 | 2019-2020 | |
| Emd Serono, INC. | $484.36 | 2019-2020 | |
| Ucb, INC. | $313.18 | 2019-2020 | |
| Biogen, INC. | $300.93 | 2019-2020 | |
| Allergan, INC. | $255.63 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $238.97 | 2019-2020 | |
| Neurocrine Biosciences, INC. | $212.61 | 2019-2020 | |
| Amgen INC. | $191.62 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $190.44 | 2019-2020 | |
| Pfizer INC. | $144.86 | 2019-2020 | |
| Adamas Pharmaceuticals, INC. | $134.88 | 2019-2020 | |
| Assertio Therapeutics, INC. | $84.84 | 2019-2020 | |
| Sk Life Science, INC. | $80.16 | 2020 | |
| Lilly USA, LLC | $73.46 | 2019-2020 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acadia Pharmaceuticals INC | $66.65 | 2019 | |
| Merck Sharp & Dohme LLC | $59.95 | 2020-2021 | |
| Lundbeck LLC | $47.20 | 2020 | |
| Catalyst Pharmaceuticals, INC. | $45.39 | 2019-2020 | |
| Neurelis, INC. | $44.08 | 2020 | |
| Upsher-Smith Laboratories LLC | $40.13 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $33.98 | 2020 | |
| Mdd US Operations, LLC | $33.56 | 2019 | |
| Genentech USA, INC. | $25.25 | 2019-2020 | |
| Acorda Therapeutics, INC | $23.45 | 2019 | |
| Kyowa Kirin, INC. | $23.18 | 2020 | |
| Alexion Pharmaceuticals, INC. | $22.94 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $21.33 | 2021 | |
| Arbor Pharmaceuticals, INC. | $18.65 | 2019 | |
| Abbvie INC. | $17.58 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harvinder Birk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.